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Background: Cationic nanoemulsions have been recently considered as potential delivery 
systems for nucleic acids. This study reports the influence of phospholipids on the properties 
of cationic nanoemulsions/DNA plasmid complexes.
Methods: Nanoemulsions composed of medium-chain triglycerides, stearylamine, egg lecithin 
or isolated phospholipids, ie, DSPC, DOPC, DSPE, or DOPE, glycerol, and water were prepared 
by spontaneous emulsification. Gene transfer to Hep G2 cells was analyzed using real-time 
polymerase chain reaction.
Results: The procedure resulted in monodispersed nanoemulsions with a droplet size and zeta 
potential of approximately 250 nm and +50 mV , respectively. The complexation of cationic 
nanoemulsions with DNA plasmid, analyzed by agarose gel retardation assay, was complete 
when the complex was obtained at a charge ratio of $1.0. In these conditions, the complexes 
were protected from enzymatic degradation by DNase I. The cytotoxicity of the complexes in 
Hep G2 cells, evaluated by MTT assay, showed that an increasing number of complexes led to 
progressive toxicity. Higher amounts of reporter DNA were detected for the formulation obtained 
with the DSPC phospholipid. Complexes containing DSPC and DSPE phospholipids, which 
have high phase transition temperatures, were less toxic in comparison with the formulations 
obtained with lecithin, DOPC, and DOPE.
Conclusion: The results show the effect of the DNA/nanoemulsion complexes composition 
on the toxicity and transfection results.
Keywords: plasmids, cationic nanoemulsions, phospholipids, physicochemical characteriza-
tion, gene transfer, stearylamine
Introduction
Gene therapy is believed by many to be the therapy of the 21st century because it aims 
to eradicate the cause rather than the symptoms of disease by delivering a normal 
functioning copy of the mutated gene and its associated regulatory elements into the 
cell nucleus.1 Thus, this type of therapy has emerged as a promising strategy for a 
wide range of inherited and acquired diseases.2 However, it has to overcome various 
hurdles to achieve efficient delivery and expression of genes at physiological levels in 
cells within the body. The development of safe and effective methods of implanting 
normal genes into human cells is one of the most important technical issues in gene 
therapy. Due to poor cell uptake and the biological instability of nucleic acids, gene 
transfer is usually performed using either viral or nonviral vectors.3International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Viral vectors have been widely used to achieve efficient 
gene transfer. However, issues related to safety, risk of 
insertional mutagenesis, and the strong immune response 
generated by these vectors has limited its application.2,4,5 
Nonviral vectors have important safety advantages over viral 
approaches, including reduced pathogenicity and capacity 
for insertional mutagenesis, as well as low cost and ease of 
production.6,7 However, application of non viral vectors has 
been held back by their poor efficiency in delivery to cells and 
transient expression of transgenes. Therefore, new strategies 
are needed for the application of these nonviral vectors as 
nucleic acid delivery systems.8,9
Nonviral vectors can be based on cationic polymers and 
lipids, with lipids showing advantages over polymers, espe-
cially regarding toxicity and biodegradability of the materi-
als used.10 Among the cationic lipid-based vectors, the ones 
most described in the literature are solid lipid nanoparticles,11 
liposomes,1,12 and nanoemulsions.7 Liposomes are vesicles 
consisting of an aqueous core enclosed in one or more 
phospholipid layers, whereas solid lipid nanoparticles and 
nanoemulsions are composed of a solid or liquid lipid oil 
core stabilized by an emulsifying layer. Regardless of the 
structure formed, all of these nonviral systems generally 
contain a cationic lipid that forms an ionic pair (complex) 
with the phosphate groups of nucleic acids.13
Cationic nanoemulsions have been more recently con-
sidered as a potential system for nucleic acid delivery.14 
The interest in these systems is justified by the fact that 
they are biocompatible and able to form complexes with 
DNA, protecting them from enzymatic degradation.7 Other 
practical advantages include ease of production and the 
potential for repeated administration.13 Furthermore, some 
authors describe that, in some cases, the in vitro and in vivo 
transfection efficiency of these systems is higher than that 
of cationic liposomes.7,12
Therefore, this study aimed to investigate the effect of dif-
ferent phospholipids on the physicochemical characteristics, 
cytotoxicity, and transfection efficiency of complexes formed 
between cationic nanoemulsions and a DNA plasmid in Hep 
G2 cells, a cell line isolated from human hepatoma.
Materials and methods
Preparation of nanoemulsions
Formulations were prepared by a spontaneous emulsification 
procedure as previously reported by Martini et al.15 Using this 
procedure, components of the oil and aqueous phase were 
dissolved in ethanol and water, respectively. The ethanol 
phase was slowly added to the water phase under moderate 
magnetic stirring which immediately turned into a milky 
phase as a consequence of emulsion formation. Solvents were 
then removed under reduced pressure below 50°C until the 
required final volume was obtained.
The final formulations were then composed of medium-
chain triglycerides (Lipoid, Ludwigshafen, Germany), 2 mM 
of the cationic lipid, stearylamine (SA, Sigma, St Louis, MO), 
different phospholipids, glycerol as an   isotonic agent (Merck, 
Brazil), and water. The phospholipids added were either 
egg lecithin containing 80%–85% phosphatidylcholine (PC, 
Lipoid) or the isolated phospholipids, 1,2-dioleoyl-  sn-glycero-
3-phosphocholine (DOPC, Lipoid), 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine  (DOPE,  Lipoid), 
1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC, Lipoid), 
or 1,2- distearoyl-sn-glycero-3-   phosphoethanolamine (DSPE, 
Lipoid). Different batches of 10 mL containing the five dif-
ferent cationic nanoemulsions (PC/SA, DSPC/SA, DOPC/
SA, DSPE/SA, and DOPE/SA) were prepared in triplicate. 
A control formulation (PC) obtained in the absence of the 
cationic lipid was also prepared. The pH of the formulations 
was adjusted to about 7.0 with HCl 0.1 M.
Plasmid DNA was isolated using MaxiPrep High Purity 
columns (Invitrogen, São Paulo, Brazil) according to the 
manufacturer’s instructions.
Physicochemical characterization
The mean droplet size, polydispersity index, and zeta potential 
of the nanoemulsions were determined by photon correla-
tion spectroscopy and electrophoretic mobility, respectively, 
at 25°C and at an angle of 90° (3000HS Zetasizer, Malvern 
Instruments, Worcestershire, UK). The samples were diluted 
in water for size determinations or in 1 mM NaCl solution for 
zeta potential measurements. Morphological examination of the 
nanoemulsions was performed by transmission electron micros-
copy (JEM-1200 ExII, Jeol, Japan). Formulations were diluted 
10 times to obtain an oil phase concentration of 1% (v/v), and 
then mixed with one droplet of 2% (w/v) uranyl acetate solution 
(Reagen, Colombo, Brazil). The samples were then adsorbed 
to the 200 mesh formvar-coated copper grids, left to dry, and 
then visualized by transmission electron microscopy. Data were 
obtained for the nanoemulsions without DNA plasmid and 
complexed with the plasmid pTracerTM-CMV2 (Invitrogen) in 
the +/- charge ratio of 2.0 (positive charge from cationic lipid     
and negative charge from DNA phosphate groups).
retention assay
Formation of complexes between nanoemulsions and 
DNA plasmid was verified by agarose gel electrophoresis. International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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  Complexes at different charge ratios (0.1, 0.5, 1.0, 2.0, 
3.0), were obtained from a combination of a fixed amount 
of DNA plasmid (55 ng) with increasing concentrations of 
  nanoemulsions. Nanoemulsions and DNA plasmid were 
incubated for 30 minutes to facilitate complex formation 
and then applied to 1% agarose gel stained with ethidium 
bromide. DNA plasmid was used without the associated 
nanoemulsion (naked) as a control.
stability assay
To determine the stability of the cationic nanoemulsions/
DNA plasmid complexes, they were submitted to a DNase I 
(Invitrogen) digestion assay. After formation of complexes 
at different charge ratios, as described above, they were 
incubated with 1 U DNase I at 37°C for 30 minutes. 
Subsequently, all the samples were submitted to phenol-
chloroform extraction16 to recover the DNA. The samples 
were then subjected to agarose gel electrophoresis. The 
naked DNA plasmid, with and without the enzyme, was 
used as the control.
cytotoxicity assay
The toxicity of the nanoemulsions and complexes was evalu-
ated in Hep G2 human hepatoma cells. Cytotoxicity was eval-
uated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT, USB Corporation, Cleveland, 
OH) assay according to Fraga et al.17 Cells were cultivated 
in Dulbecco’s Modified Eagle Medium containing 10% fetal 
bovine serum (Gibco, Grand Island, NY) and seeded at a 
density of 1 × 104 cells/well in a 96-well plate for 48 hours 
before the assay. Increasing charge ratios of the complexes 
were incubated with Hep G2 cells for 24 hours, then the 
medium was removed and MTT solution 0.5 mg/mL was 
added. Cells were maintained under incubation for 4 hours. 
After that, 100 µL of dimethylsulfoxide (Synth Solutions, 
São Paulo, Brazil) was added to dissolve the blue formazan 
crystals. The optical density was measured at 570 nm using 
a plate reader (Anthos, Hamburg, Germany) after adjust-
ing the pH with Sorensen’s glycine buffer. Cells incubated 
only in Dulbecco’s Modified Eagle Medium were used as 
a control for 100% cellular viability, while 0% of cellular 
viability was obtained after incubation of cells with Triton 
X-100 (2%, w/v).
gene transfer
Hep G2 cells were seeded at 2 × 105 cells/well in a 24-well 
plate and grown to 70%–80% confluence. Gene   transfer 
was performed by incubating the cells with cationic 
  nanoemulsions/DNA plasmid complexes at a charge ratio 
of 2.0 for 4 hours. The DNA plasmid used was pTracerTM 
CMV2, a plasmid which contains the reporter gene green 
fluorescent protein. As a positive control for transfec-
tion, DNA plasmid was associated with the commercial 
reagent, Lipofectamine 2000® (Invitrogen) following 
the manufacturer’s instructions. Twenty-four hours after 
transfection, DNA from Hep G2 cells was extracted using 
an Easy DNA Kit (Invitrogen). Green fluorescent protein 
quantification was performed by real-time polymerase 
chain reaction with TaqMan® MGB probes which were 
FAMTM dye-labeled (Applied Biosystems, Foster City, 
CA). The following sequences were used: forward primer 
5′-CCACATGGTCCTTCTTGAGTTTGTA-3′, reverse 
primer 5′-GAACGGCACTGGTCAACTTG-3′, and probe 
5′-TCCATGCCATGTGTAATC-3′. The polymerase chain 
reaction was carried out according to the manufacturer’s 
instructions, using 10 µL of TaqMan Universal PCR Master 
Mix, No AmpErase® UNG (2×), 1 µL of 20× Assay Mix, 
and 100 ng of DNA in a volume of 20 µL (Applied Biosys-
tems). All the reactions were performed in duplicate using 
the ABI Prism® 7500 SDS (Applied Biosystems). Plasmid 
concentrations ranging from 0.001 ng to 5 ng were used for 
the standard curve.
statistical analysis
Results are expressed as the mean ± standard deviation of 
three independent experiments. Statistical analysis of the 
data was performed using Student’s t-test, one-way analysis 
of variance with Tukey post hoc or independent-samples 
Kruskal–Wallis testing on PASW (v 18.0; SPSS, Chicago, 
IL). Differences were considered to be statistically significant 
at P , 0.05.
Results
Physicochemical characterization
Droplet size ranged from 230 nm to 280 nm regardless of 
whether PC or isolated phospholipids were used (Table 1). 
The cationic nanoemulsion/DNA plasmid complexes showed 
a mean droplet size of about 300 nm, with a polydispersity 
index of approximately 0.2–0.3.
The PC/DNA plasmid formulation showed a negative zeta 
potential of about 54 mV in a module which was significantly 
higher than that found before complexation (P , 0.05). 
Higher zeta potentials were observed for formulations con-
taining the isolated phospholipids (regardless of type) when 
compared with those stabilized by the binary mixture of 
lecithin and SA (P , 0.01; Table 1).International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Photomicrographs showed spherical oil droplets of 
200–300 nm, demonstrating a defined edge and staining with 
uranyl acetate (Figure 1) according to photon correlation 
spectroscopy. No marked influence of type of phospholipid 
used was detected, nor of presence of the SA cationic lipid 
or DNA plasmid on the morphology of the structure.
retention assay
The results of retardation of DNA plasmid migration in agarose 
gel electrophoresis with different charge ratios are shown in 
Figure 2. Figure 2A demonstrates DNA plasmid migration in 
the PC formulation free of the SA cationic lipid. It is observed 
that there is no nucleic acid complexation with the nanostruc-
ture, with the DNA plasmid being soluble in the external phase 
of the nanoemulsion. On the other hand, regardless of the type 
of phospholipid used, for all cationic nanoemulsions containing 
SA, retention of the complex was observed at the application 
point from the charge ratio of 1.0 (Figure 2B–F).
stability assay
The presence of characteristic bands of intact DNA plasmid 
was noticed after incubation with DNAse I, indicating that 
complexation with cationic nanoemulsions protects DNA 
plasmid from enzymatic digestion (Figure 3). Results were 
similar for the formulations obtained with the different phos-
pholipids. The same did not occur with DNA plasmid added 
to the noncationic PC formulation, suggesting that there is 
no DNA complexation in this nanoemulsion.
cytotoxicity assay
The cytotoxicity assay demonstrated that addition of increasing 
amounts of complexes and consequently of the cationic SA 
lipid, leads to progressive toxicity in Hep G2 cells (  Figure 4). 
Among the complexes evaluated, those obtained from egg leci-
thin (PC/SA) and isolated phospholipids DOPC (DOPC/SA) 
and DOPE (DOPE/SA) were the most toxic, showing reduction 
of cell viability by up to 80% for a charge ratio of 12.0. On the 
other hand, after incubation of Hep G2 cells with the DSPC/
SA and DSPE/SA complexes, cell viability was about 60% and 
40%, respectively, for the charge ratio of 12.0 (P , 0.001, one-
way analysis of   variance). The control formulation composed 
by medium-chain triglycerides and egg lecithin (PC) showed 
cell viability of about 80% at any analyzed point.
gene transfer
In the last step of this work, the green fluorescent protein 
gene present in pTracer-CMV2 was used as a reporter gene 
to evaluate transfection efficiency. Table 2 shows the results 
for the different formulations, as well as for the positive con-
trol Lipofectamine 2000. Among the different formulations 
tested, the highest efficiency was obtained for the formula-
tion DSPC/SA, followed by DSPE/SA. However, both were 
lower than Lipofectamine 2000, although without statistical 
significance (P . 0.05).
Discussion
We recently reported the development of lecithin-based 
nanoemulsions obtained by spontaneous emulsification as 
delivery systems for nucleic acids.6,15 Following up on these 
results, in this study we investigated the effect of different 
isolated phospholipids on the physicochemical properties, 
cytotoxicity, and transfection of nanoemulsions/DNA plas-
mid complexes on Hep G2 cells.
Regardless of the nature of the phospholipids (egg leci-
thin or isolated phospholipids), the droplet size of the nano-
emulsions remained in the 250–280 nm range, highlighting 
the effect of spontaneous emulsification conditions rather 
than composition of the formulations on this physicochemi-
cal property. This follows in line with previous literature 
showing that the size of colloidal carriers obtained by solvent 
Table 1 Physicochemical properties of nanoemulsions and complexes
Nanoemulsions Complexes
Mean diameter* 
(nm)
Zeta potential 
(mV)
Mean diameter* 
(nm)
Zeta potential 
(mV)
Pc  231 ± 22 -36.8 ± 3.4† 334 ± 15 -54.0 ± 1.4
Pc/sA 265 ± 14 +53.3 ± 4.8‡ 298 ± 3 +52.1 ± 1.6
DsPc/sA 274 ± 27 +67.5 ± 2.3† 294 ± 13 +52.2 ± 3.0
DOPc/sA 272 ± 9 +67.0 ± 2.0 300 ± 17 +61.3 ± 4.5
DsPe/sA 270 ± 14 +67.3 ± 6.4 306 ± 23 +55.5 ± 3.5
DOPe/sA 279 ± 20 +67.5 ± 3.5† 314 ± 8 +57.7 ± 3.8
Notes: *results represent the mean ± standard deviation of three experiments; †Difference between ζ-potential measurements before and after complexation with pDNA 
(student’s T-test, P , 0.05); ‡Difference among ζ-potential measurements of Pc/sA compared to isolated phospholipids (One-way analysis of variance, Tukey post-hoc, 
P , 0.01).
Abbreviations:  Pc,  phosphatidylcholine;  sA,  stearylamine;  DOPc,  1,2-dioleoyl-sn-glycero-3-phosphocholine;  DOPe,  1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; 
DsPc, 1,2-distearoyl-sn-glycero-3-phosphocholine; DsPe, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 1 Transmission electron micrographs of the complexes formed between 
nanoemulsions/DNA  phosphatidylcholine  (A),  phosphatidylcholine/stearylamine 
(B), and 1,2-distearoyl-sn-glycero-3-phosphocholine/stearylamine (C) in the charge 
ratio of 2.0. 100,000× magnification.
M DNA 0.1 0.5 123
M DNA 0.1 0.5 123
M DNA 0.1 0.5 123
M DNA 0.1 0.5 123
M DNA 0.1 0.5 123
M DNA 0.1 0.5 123
AB
CD
EF
Figure  2  Migration  of  complexes  formed  between  nanoemulsions/DNA  plasmid 
phosphatidylcholine  (A),  phosphatidylcholine/stearylamine  (B),  1,2-distearoyl-  sn-
glycero-3-phosphocholine/stearylamine  (C),  1,2-dioleoyl-sn-glycero-3-phosphocholine/
stearylamine (D), 1,2- distearoyl-sn-glycero-3- phosphoethanolamine/stearylamine (E), 
and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine/stearylamine (F) in 1% agarose 
gel. M = 1 Kb DNA ladder; DNA plasmid = 0.1, 0.5, 1.0, 2.0, and 3.0 charge ratio of 
cationic nanoemulsions/DNA plasmid.
displacement methods seems to be mainly influenced by 
the diffusion speed of the organic solvent in water.6,18 In the 
final pH of the formulations, the zeta potential, which was 
stabilized by zwitterionic PC or phosphatidylethanolamine 
in a binary mixture with SA, was highly positive (.50 mV). 
Formulations containing isolated phospholipids showed 
significantly higher zeta potentials than that detected for 
the PC/SA formulation. A plausible explanation for this 
higher positive surface charge, at the same cationic lipid 
content, could be related to a partial neutralization of SA 
molecules by the negatively charged phospholipids from 
egg lecithin.
Cationic nanoemulsion/DNA plasmid complexation 
was evaluated using a mobility shift assay as a function 
of the complex charge ratio. Our results showed complete 
association of cationic nanoemulsions with DNA plasmid 
beyond a charge ratio of 1.0. DNA plasmid adsorption led 
to a slight increase in the droplet size of the complexes. 
  However, no evidence of oil droplet flocculation was detected, 
at least for complexes obtained at a charge ratio of 2.0, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 4 Viability of Hep G2 cells after incubation during 24 hours with nanoemulsions of phosphatidylcholine (◊), phosphatidylcholine/stearylamine (°), 1,2-distearoyl-
sn-glycero-3-phosphocholine/stearylamine (∆), 1,2-dioleoyl-sn-glycero-3-phosphocholine/stearylamine (), 1,2- distearoyl-sn-glycero-3- phosphoethanolamine/stearylamine 
() and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine/stearylamine () complexed with DNA plasmid at different charge ratios.
M DNA ab0.10 .5 12 3M DNAa b 0.1 0.5 12 3
M DNA ab0.10 .5 12 3M DNAa b 0.1 0.5 12 3
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Figure  3  Migration  of  complexes  formed  between  nanoemulsions/DNA  plasmid 
phosphatidylcholine  (A),  phosphatidylcholine/stearylamine  (B),  1,2-distearoyl-sn-
glycero-3-phosphocholine/stearylamine (C), 1,2-dioleoyl-sn-glycero-3-phosphocholine/
stearylamine (D), 1,2- distearoyl-sn-glycero-3- phosphoethanolamine/stearylamine (E), 
and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine/stearylamine (F) in 1% agarose 
gel, after 30 minutes of incubation with DNase I. M = 1 Kb DNA ladder; DNA plasmid 
(a) = naked DNA plasmid, (b) = DNA plasmid + DNase I 0.1, 0.5, 1.0, 2.0, and 3.0 charge 
ratio of cationic nanoemulsions/DNA plasmid.
as attested by transmission electron microscopy images. 
Such interactions were strong enough to protect the DNA 
plasmid against enzymatic digestion by DNAse I over a 
30-minute incubation time. DNA plasmid was retrieved in its 
  different isoforms, ie, supercoiled, linear, and open   circular. 
  Electrostatic interactions between positively charged groups 
of SA and negatively charged phosphate groups of nucleic 
acids have been considered as the main force leading to 
nucleic acid adsorption and protection against enzymatic 
degradation.19–21
To assess the toxicity of the complexes, cell viability 
was determined using a MTT test in previous optimized 
  conditions.17 In the PC/SA formulation, cell viability 
decreased progressively upon increasing the charge ratio, 
indicating the toxicity of the cationic SA lipid. Similar 
features were detected for complexes containing DOPE and 
DOPC phospholipids. Senior et al22 related the cytotoxicity 
of SA-based colloidal carriers to the lability of this single-
tailed cationic lipid at the interfaces, leading to its migration 
and consequent direct interaction with cell membranes. Con-
versely, when phospholipids exhibiting high phase-transition 
temperatures (DSPC and DSPE) were used instead of fluid 
ones (DOPC and DOPE), a significant reduction in Hep G2 
toxicity could be observed, indicating the effect of these 
phospholipids in reducing the cytotoxicity of the complexes. 
Such results could be related to the more stable interface of 
formulations containing phospholipids bearing rigid chains 
when compared with their fluid counterparts, as supported 
by previous literature.23
The effect of phospholipid composition on nano-
emulsions for Hep G2 cell transfection was evaluated 
by real-time polymerase chain reaction. Higher levels of 
green fluorescent protein were detected for complexes 
composed of SA and rigid phospholipids (DSPE and 
DSPC) at values similar to those of the positive control, 
Lipofectamine 2000. It has been previously postulated International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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that SA located at the o/w interface of nanoemulsions can 
induce a lysosomal escape mechanism due to its interaction 
with anionic lipids on the lysosomal membrane, leading to 
cell transfection.19 It should be mentioned that, contrary to 
our expectation, the DOPE-containing formulation did not 
improve transfection on Hep G2 cells. The literature for 
liposome technology has documented the positive effect 
of this phospholipid on transfection efficiency due to its 
ability to form an inverted hexagonal phase.1,24 We can 
speculate that a more stable interface obtained from rigid 
phospholipids could also lead to more stable complexes, 
thereby improving transfection efficiency in the case of 
DSPC and DSPE phospholipids. However, nanoemulsions 
containing DOPE need optimization of the formulation in 
terms of the DOPE/cationic lipid ratio and the combination 
of phospholipids with nonionic surfactants, as recently 
reported.24,25
Conclusion
This study shows the influence of phospholipid composition 
on the physicochemical properties of nanoemulsion. 
Complexation of cationic nanoemulsions with DNA plasmid 
occurred from the charge ratio of 1.0 for all the cationic 
emulsions, protecting DNA plasmid from degradation by the 
DNase I enzyme. Toxicity of cationic nanoemulsion/DNA 
plasmid complexes is mainly related to the presence of the 
cationic SA lipid, but a higher cytotoxicity was observed for 
formulations containing fluid phospholipids (DOPC, DOPE, 
and egg lecithin) in comparison with rigid phospholipids 
(DSPC and DSPE). Using a real-time polymerase chain 
reaction technique, it was possible to demonstrate the 
potential of the cationic nanoemulsions developed in this 
study as a gene transfer system in Hep G2 cells, with the 
higher transfection efficiency being detected for the DSPC/
SA formulation.
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